Citadel Discovery logo

Citadel Discovery

AI/ML Driven Drug Discovery: Accelerate. De-risk, Expand

1 employees · est. 2021 · Cambridge, United States

VS
Genesis Molecular AI logo

Genesis Molecular AI

Unifying AI and Biotech to accelerate the discovery of new medicines

158 employees · est. 2019 · San Mateo, United States

Genesis Molecular AI is the older company (2021 vs 2019); Genesis Molecular AI is the larger of the two.

Side-by-Side Comparison

Citadel Discovery Genesis Molecular AI
Founded
2021 2019 older
Headquarters
Cambridge, United States San Mateo, United States
Employees
1 158 larger
Industry
AI, Pharmaceutical AI, Biotechnology, Information Technology
Funding Stage
Non Equity Assistance Unknown
Total Funding
Not tracked yet $280.13M
Funding Rounds
1 5
Services
web hosting services, hosting provider services AI Research and Development, Molecular Design Platforms, Drug Discovery Solutions, AI Model Capabilities Enhancement
Target Customers
Not tracked yet Pharmaceutical Companies, Biotechnology Firms, Research Institutions, Drug Development Teams
Taxonomy
AI-driven Drug Discovery, Pharmaceutical Industry, Biological Exploration, Data Sharing Platform, Therapeutic Discovery, DNA Encoded Libraries, Precision Medicine, Healthcare Technologies, Public Benefit Corporation, Global Health, Data Access For Academia, Supply Chain And Logistics, Data Generation, Rapid Validation, Not-for-profit Partnerships Molecular AI, Drug Discovery, Generative AI, Predictive AI, GEMS Platform, Small Molecule Drugs, Structure Prediction, AI-Enabled Discovery, Lead Optimization, Biophysics Simulation, Neural Networks, Computational Chemistry, Undruggable Targets, AI Collaborations, Pharmaceutical Innovation
Website
citadeldiscovery.io genesistherapeutics.ai
Citadel Discovery logo

About Citadel Discovery

Citadel Discovery, founded in 2021 in the United States, is carving a niche in the AI and Pharmaceutical industries with its innovative approach to drug discovery. The company markets itself under the slogan: "AI/ML Driven Drug Discovery: Accelerate. De-risk, Expand." Their vision is to overcome the...

Genesis Molecular AI logo

About Genesis Molecular AI

Genesis Molecular AI, founded in 2019 and headquartered in the United States, is at the forefront of merging AI and Biotechnology to enhance drug discovery processes. With an innovative slogan, “Unifying AI and Biotech to accelerate the discovery of new medicines,” the company is redefining drug des...

We will tell you when either one moves

BounceWatch watches Citadel Discovery and Genesis Molecular AI for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Citadel Discovery and Genesis Molecular AI — by email.

Frequently Asked Questions

Citadel Discovery — AI/ML Driven Drug Discovery: Accelerate. De-risk, Expand. Genesis Molecular AI — Unifying AI and Biotech to accelerate the discovery of new medicines. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Citadel Discovery has raised undisclosed funding while Genesis Molecular AI has raised $280.13M.
Citadel Discovery and Genesis Molecular AI operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Citadel Discovery with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Citadel Discovery on 11 Jun 2025, and Genesis Molecular AI on 18 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy